or
forgot password

    • cancer clinical trials in oxnard, CA

    • Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    P.M.K. Medical Group, Inc.
    Oxnard, California 93030
    Colorectal Cancer
    Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
    P.M.K. Medical Group, Inc.
    Oxnard, California 93030
    Colorectal Cancer
    Treatment of HER2-Positive Metastatic Breast Cancer With Herceptin and Bevacizumab (Antibodies Against HER2 and VEGF)
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Breast Cancer
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Myeloid Leukemia, Chronic, Chronic-Phase
    Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
    Ventura County Hematology Oncology Specialists
    Oxnard, California 93030
    Chronic Lymphocytic Leukemia
    Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Colorectal Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Ventura Co Hem-Onc Specialists
    Oxnard, California 93030
    Non-Small Cell Lung Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Ventura County Hematology-Oncology Specialist
    Oxnard, California 93030
    Breast Cancer
    Patients With Advanced Non-Small Cell Lung Cancer
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Non-Small Cell Lung Carcinoma
    A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
    Location #39
    Oxnard, California 93030
    Metastatic Breast Cancer
    Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
    PMK Medical Group, Inc., dba Ventura County Hematology Oncology Specialists
    Oxnard, California 93030
    Ovarian Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    PMK Medical Group, Inc. DBA Ventura
    Oxnard, California 93030
    Chronic Myeloid Leukemia
    Phase 1 and 2 Study of PX-866 and Cetuximab
    Ventura County Hematology Oncology Specialists
    Oxnard, California 93030
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    PMK Medical Group, Inc., dba Ventura County Hematology Oncology Specialists
    Oxnard, California 93030
    Advanced Prostate Cancer, Prostatic Neoplasms
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    PMK Medical Group, Inc.
    Oxnard, California 93030
    Non Small Cell Lung Cancer
    A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
    PMK Medical Group
    Oxnard, California
    ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer Patients
    Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
    PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists
    Oxnard, California 93030
    Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Multiple Myeloma, Solid Tumors
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    PMK Medical Group, Inc., dba Ventura County Hematology Oncology Specialists
    Oxnard, California 93030
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    St.Johns Regional Hospital and Medical Center
    Oxnard, California 93030
    ST Segment Elevation Myocardial Infarction
    A Extension Study of Idelalisib for Patients With Chronic Lymphocytic Leukemia Who Participated in GS-US-312-0116
    Ventura County Hematology Oncology Specialists
    Oxnard, California 93030
    Chronic Lymphocytic Leukemia
    Phase 2 Study of EC145 Alone Versus EC145+Docetaxel Versus Docetaxel Alone in Participants With FR(++) 2nd Line Non Small Cell Lung Cancer
    Ventura County Hematology Oncology Specialists

    Trial Locations
    Ventura County Hematology Oncology Specialists
    PMK Medical Group, Inc. DBA Ventura County Hematology Oncology Specialists
    Non Small Cell Lung Cancer
    Irinotecan in Treating Patients With Esophageal or Stomach Cancer
    Ventura County Hematology-Oncology Medical Group, Inc.
    Oxnard, California 93030
    Esophageal Cancer, Gastric Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Ventura Hematology - Oncology Specialists - Oxnard
    Oxnard, California 93030
    Breast Cancer
    Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Lymphoma, Non-Hodgkin
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)
    Ventura County Hematology-Oncology Specialists (TORI)
    Oxnard, California 93030
    Non-Small-Cell Lung Carcinoma, Neoplasm Recurrence, Local
    A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Ventura County Hematology Oncology Specialists
    Oxnard, California 93030
    Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Prostate Cancer
    Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Prostate Cancer
    Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Carcinoma, Non-Small-Cell Lung
    Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Non-Hodgkin's Lymphoma
    Study of EC145 in Patients With Advanced Ovarian and Endometrial Cancers
    Ventura County Hematology-Oncology
    Oxnard, California 93030
    Ovarian Cancer, Endometrial Cancer
    Study of EC145 in Patients With Progressive Adenocarcinoma of the Lung
    Ventura County Hematology-Oncology
    Oxnard, California 93030
    Adenocarcinoma of the Lung
    Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHL
    Ventura County Hematology Oncology Specialist
    Oxnard, California 93030
    Non-Hodgkin's Lymphoma
    Cognition in the Study of Tamoxifen and Raloxifene
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Cognition, Aging
    Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non‑Small Cell Lung Cancer
    Ventura County Hematology-Oncology Specialists
    Oxnard, California 93030
    Non-small Cell Lung Cancer
    A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
    Ventura County Hematology/Oncology Specialists
    Oxnard, California 93030
    Non-Small Cell Lung Cancer
    Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer
    Diverse Research Solutions
    Oxnard, California 93030
    Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer
    Head to Head Study Epi proColon and FIT
    Diverse Research Solutions, LLC
    Oxnard, California 93030
    Colorectal Cancer